A pharmacoeconomic analysis of topical therapies for patients with mild-to-moderate stable plaque psoriasis: a US study
- 1 July 1998
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 20 (4), 851-869
- https://doi.org/10.1016/s0149-2918(98)80146-x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Long-term Effectiveness and Safety of Topical Calcipotriene for PsoriasisSouthern Medical Journal, 1996
- Safety, efficacy and duration of therapeutic effect of tazarotene used in the treatment of plaque psoriasisBritish Journal of Dermatology, 1996
- Tazarotene-first of a new generation of receptor-selective retinoidsBritish Journal of Dermatology, 1996
- Safety and efficacy of calcipotriol ointment (Dovonex®) in treating children with psoriasis vulgarisBritish Journal of Dermatology, 1996
- Treatment of PsoriasisNew England Journal of Medicine, 1995
- Comparative study of calcipotriene (MC 903) ointment and fluocinonide ointment in the treatment of psoriasisJournal of the American Academy of Dermatology, 1994
- Therapeutic progress II: treatment of psoriasisJournal of Clinical Pharmacy & Therapeutics, 1994
- Markov Models in Medical Decision MakingMedical Decision Making, 1993
- The annual cost of psoriasisJournal of the American Academy of Dermatology, 1993
- Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgarisJournal of the American Academy of Dermatology, 1992